WITHDRAWN: Phosphodiesterase-5 inhibitors in Pregnancy: Systematic review and meta-analysis of maternal and perinatal safety and clinical outcomes

Am J Obstet Gynecol. 2021 Jun 8:S0002-9378(21)00637-2. doi: 10.1016/j.ajog.2021.06.006. Online ahead of print.

Abstract

This article has been withdrawn at the request of the author(s) and/or editor. The Publisher apologizes for any inconvenience this may cause.

Keywords: Phosphodiesterase-5 inhibitors; Sildenafil Citrate; Tadalafil; fetus; meta-analysis; pregnancy; systematic review.

Publication types

  • Review